Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Alzheimer's Disease

Free Subscription 05.06.2023 5 Alzheimer Dis Assoc Disord 7 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 2 Ann Neurol 1 BMC Geriatr 1 BMC Neurol 5 Brain 1 Brain Res 3 Curr Alzheimer Res 8 J Alzheimers Dis 1 J Am Geriatr Soc 3 J Biol Chem 1 J Neurochem 1 J Neurosci 1 Nat Med 3 Nat Neurosci 1 Nat Rev Neurosci 1 Nature 1 Neurology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimer Dis Assoc Disord

1. SADHUKHAN D, Mallick A, Mishra S, Mukherjee A, et al
   An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing.
   Alzheimer Dis Assoc Disord. 2023;37:164-167.
   PubMed         Abstract available
   
   
2. VAN HEZIK-WESTER VJ, Handels RLH, Wolfs CAG, Kanters TA, et al
   Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
   Alzheimer Dis Assoc Disord. 2023;37:134-141.
   PubMed         Abstract available
   
   
3. GABEL M, Denny A, Llibre-Guerra J, Morris JC, et al
   Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities.
   Alzheimer Dis Assoc Disord. 2023;37:107-112.
   PubMed         Abstract available
   
   
4. SHAW AR, Lofton S, Vidoni ED
   A Virtual Photovoice Study of Older African Americans Perceptions of Neurovascular Clinical Trials.
   Alzheimer Dis Assoc Disord. 2023;37:113-119.
   PubMed         Abstract available
   
   
5. MASCARENHAS FONSECA L, Sheppard DP, Chaytor NS
   MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes.
   Alzheimer Dis Assoc Disord. 2023;37:152-155.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

6. HUBER H, Ashton NJ, Schieren A, Montoliu-Gaya L, et al
   Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults.
   Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13163.
   PubMed         Abstract available
   
   
7. HAMMERS DB, Nemes S, Diedrich T, Eloyan A, et al
   Learning slopes in early-onset Alzheimer's disease.
   Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13159.
   PubMed         Abstract available
   
   
8. LUTZ MW, Chiba-Falek O
   Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variants.
   Alzheimers Dement. 2023 May 30. doi: 10.1002/alz.13168.
   PubMed         Abstract available
   
   
9. HAMMERS DB, Eloyan A, Taurone A, Thangarajah M, et al
   Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
   Alzheimers Dement. 2023 May 31. doi: 10.1002/alz.13160.
   PubMed         Abstract available
   
   
10. LI D, Farrell JJ, Mez J, Martin ER, et al
    Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13117.
    PubMed         Abstract available
    
    
11. KRONIMUS Y, Albus A, Hasenberg M, Walkenfort B, et al
    Fc N-glycosylation of autoreactive Abeta antibodies as a blood-based biomarker for Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13124.
    PubMed         Abstract available
    
    
12. KNAPSKOG AB, Aksnes M, Edwin TH, Ueland PM, et al
    Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 2. doi: 10.1002/alz.13162.
    PubMed         Abstract available
    
    

    
    Am J Alzheimers Dis Other Demen

13. RUGGERO L, Croot K, Nickels L
    Quality of Life Ratings and Proxy Bias in Primary Progressive Aphasia: Two Sides to the Story?
    Am J Alzheimers Dis Other Demen. 2023;38:15333175231177668.
    PubMed         Abstract available
    
    

    
    Ann Neurol

14. NELSON PT, Schneider JA, Jicha GA, Duong MT, et al
    When Alzheimer's is LATE: Why does it matter?
    Ann Neurol. 2023 May 28. doi: 10.1002/ana.26711.
    PubMed         Abstract available
    
    
15. DE KORT AM, Kuiperij HB, Marques TM, Jakel L, et al
    Decreased Cerebrospinal Fluid Amyloid beta 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
    Ann Neurol. 2023;93:1173-1186.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

16. ALBALAWI A
    Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson's disease: a case report.
    BMC Geriatr. 2023;23:344.
    PubMed         Abstract available
    
    

    
    BMC Neurol

17. ZHANG J, Zheng X, Zhao Z
    A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
    BMC Neurol. 2023;23:210.
    PubMed         Abstract available
    
    

    
    Brain

18. ROBINSON JL, Xie SX, Baer DR, Suh E, et al
    Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
    Brain. 2023;146:2557-2569.
    PubMed         Abstract available
    
    
19. EDWARDS HM, Wallace CE, Gardiner WD, Doherty BM, et al
    Sex-dependent effects of acute stress on amyloid-beta in male and female mice.
    Brain. 2023;146:2268-2274.
    PubMed         Abstract available
    
    
20. DAS V, Hajduch M
    Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
    Brain. 2023 May 27:awad177. doi: 10.1093.
    PubMed        
    
    
21. ZHU M, Xiao B, Xue T, Qin S, et al
    Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
    Brain. 2023 May 31:awad184. doi: 10.1093.
    PubMed         Abstract available
    
    
22. 
    Correction: The most valuable player or the tombstone: is tau the correct target to treat Alzheimer's disease?
    Brain. 2023 Jun 1:awad176. doi: 10.1093.
    PubMed        
    
    

    
    Brain Res

23. HASAN SMN, Clarke C, Strand T, Bambico FR, et al
    Putative pathological mechanisms of late-life depression and Alzheimer's disease.
    Brain Res. 2023;1813:148423.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

24. TARIQ R, Kansal B, Shaikh R, Datta S, et al
    Outcomes and Factors Affecting Transcranial Direct Current Stimulation in Alzheimer's Disease Patients: A Systematic Review.
    Curr Alzheimer Res. 2023 Jun 1. doi: 10.2174/1567205020666230601095957.
    PubMed         Abstract available
    
    
25. SHIH PY, Yong SB, Liu CM, Cheng-Chung Wei J, et al
    Is Vitamin D Supplementation a danger to potential treatments of Alzheimer's Disease Treatment?
    Curr Alzheimer Res. 2023 May 30. doi: 10.2174/1567205020666230530095421.
    PubMed        
    
    
26. CUI J, Chen D, Zhang J, Qin Y, et al
    Landmark Model-Based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease using Cognitive Screening.
    Curr Alzheimer Res. 2023 May 26. doi: 10.2174/1567205020666230526101524.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

27. LIU M, Li M, He J, He Y, et al
    Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
    PubMed         Abstract available
    
    
28. JARHOLM JA, Bjornerud A, Dalaker TO, Akhavi MS, et al
    Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
    PubMed         Abstract available
    
    
29. FINDLEY CA, McFadden SA, Cox MF, Sime LN, et al
    Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
    PubMed         Abstract available
    
    
30. LIU J, Xie Y, Lu Y, Zhao Z, et al
    APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and Inflammation.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
    PubMed         Abstract available
    
    
31. KARIMA S, Aghamollaii V, Mahmoodi Baram S, Balenci L, et al
    Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
    PubMed         Abstract available
    
    
32. GONZALEZ A, Calfio C, Luttges V, Gonzalez-Madrid A, et al
    The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as the Major Contributor.
    J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
    PubMed         Abstract available
    
    
33. HAZAN J, Liu K, Fox N, Howard R, et al
    Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the Diagnostic Process.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
    PubMed         Abstract available
    
    
34. SUN L, Ye KX, Wong HLK, Wang L, et al
    The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

35. TAYLOR B, Barboi C, Boustani M
    Passive digital markers for Alzheimer's disease and other related dementias: A systematic evidence review.
    J Am Geriatr Soc. 2023 May 30. doi: 10.1111/jgs.18426.
    PubMed         Abstract available
    
    

    
    J Biol Chem

36. TIWARI A, Pradhan S, Sannigrahi A, Mahakud AK, et al
    Interplay of lipid head group and packing defects in driving amyloid-beta-mediated myelin-like model membrane deformation.
    J Biol Chem. 2023;299:104653.
    PubMed         Abstract available
    
    
37. SCHMIDT FC, Fitz K, Feilen LP, Okochi M, et al
    Different transmembrane domains determine the specificity and efficiency of the cleavage activity of the gamma-secretase subunit presenilin.
    J Biol Chem. 2023;299:104626.
    PubMed         Abstract available
    
    
38. KOTIYA D, Leibold N, Verma N, Jicha GA, et al
    Rapid, scalable assay of amylin-beta amyloid co-aggregation in brain tissue and blood.
    J Biol Chem. 2023;299:104682.
    PubMed         Abstract available
    
    

    
    J Neurochem

39. BARINGER SL, Simpson IA, Connor JR
    Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
    J Neurochem. 2023;165:625-642.
    PubMed         Abstract available
    
    

    
    J Neurosci

40. LANDRY O, Francois A, Oye Mintsa Mi-Mba MF, Traversy MT, et al
    Postsynaptic protein Shank3a deficiency synergizes with Alzheimer's disease neuropathology to impair cognitive performance in the 3xTg-AD murine model.
    J Neurosci. 2023 May 30:JN-RM-1945-22. doi: 10.1523/JNEUROSCI.1945-22.2023.
    PubMed         Abstract available
    
    

    
    Nat Med

41. BELLAVER B, Povala G, Ferreira PCL, Ferrari-Souza JP, et al
    Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer's disease.
    Nat Med. 2023 May 29. doi: 10.1038/s41591-023-02380.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

42. ZHAO Y, Zheng Q, Hong Y, Gao Y, et al
    beta(2)-Microglobulin coaggregates with Abeta and contributes to amyloid pathology and cognitive deficits in Alzheimer's disease model mice.
    Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01352.
    PubMed         Abstract available
    
    
43. SUN N, Akay LA, Murdock MH, Park Y, et al
    Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer's disease.
    Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01334.
    PubMed         Abstract available
    
    
44. 
    beta2-Microglobulin boosts beta-amyloid aggregation and neurotoxicity in an Alzheimer's disease model.
    Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01354.
    PubMed        
    
    

    
    Nat Rev Neurosci

45. LEAKE I
    Oligomeric tau might spread trans-synaptically in Alzheimer disease.
    Nat Rev Neurosci. 2023 May 26. doi: 10.1038/s41583-023-00714.
    PubMed        
    
    

    
    Nature

46. DEPP C, Sun T, Sasmita AO, Spieth L, et al
    Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer's disease.
    Nature. 2023 May 31. doi: 10.1038/s41586-023-06120.
    PubMed         Abstract available
    
    

    
    Neurology

47. GROBER E, Petersen KK, Lipton RB, Hassenstab J, et al
    Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals.
    Neurology. 2023;100:e2279-e2289.
    PubMed         Abstract available
    
    

    
    PLoS One

48. SU Y, Wang D, Liu N, Yang J, et al
    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis.
    PLoS One. 2023;18:e0286086.
    PubMed         Abstract available
    
    
49. BRAUN DJ, Frazier HN, Davis VA, Coleman MJ, et al
    Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    PLoS One. 2023;18:e0286495.
    PubMed         Abstract available
    
    
50. RADWAN AA, Alanazi FK, Raish M
    Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
    PLoS One. 2023;18:e0286195.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: